Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes
More topics under "A61K - Preparations for medical, dental, or toilet purposes" (2,585,043)
A61K 101 - Radioactive non-metals (526)
A61K 103 - Radioactive metals (481)
A61K 125 - Containing or obtained from roots, bulbs, tubers, corms or rhizomes (2,645)
A61K 127 - Containing or obtained from leaves (1,806)
A61K 129 - Containing or obtained from bark (325)
A61K 131 - Containing or obtained from seeds, nuts, fruits or grains (1,932)
A61K 133 - Containing or obtained from flowers or blossoms (665)
A61K 135 - Containing or obtained from stems, stalks, branches, twigs or shoots (756)
A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
A61K 33 - Medicinal preparations containing inorganic active ingredients (56,213)
A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838)
A61K 36 - Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines (179,316)
A61K 38 - Medicinal preparations containing peptides (316,240)
A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
A61K 41 - Medicinal preparations obtained by treating materials with wave energy or particle radiation (9,445)
A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
A61K 49 - Preparations for testing in vivo (35,376)
A61K 50 - Electrically conductive preparations for use in therapy or testing in vivo, e.g. conductive adhesives or gels to be used with electrodes for electrocardiography (ecg) or for transcutaneous drug administration (62)
A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291)
A61K 6 - Preparations for dentistry (18,259)
A61K 8 - Cosmetics or similar toilet preparations (170,551)
A61K 9 - Medicinal preparations characterised by special physical form (299,044)
Patents for A61K - Preparations for medical, dental, or toilet purposes (29,449)
07/2012
07/17/2012US8222451 Histone deacetylase inhibitors and methods of use thereof
07/17/2012US8222008 Methods and compositions for treating cancer
07/17/2012US8221988 Methods and compositions relating to CCR5 antagonist, IFN-γ and IL-13 induced inflammation
07/17/2012US8221771 Formulations containing an immune response modifier
07/17/2012US8221763 Yeast-antigen compositions and methods of using the same
07/17/2012CA2522888C Smooth muscle spasmolytic agents
07/17/2012CA2522561C Quinoxalinyl macrocyclic hepatitis c serine protease inhibitors
07/17/2012CA2488366C Biofunctional cpg or oligo-/polynucleotide and toxin or enterotoxin containing composition
07/12/2012US20120179143 Process for in vivo treatment of specific biological targets in bodily fluids
07/12/2012US20120177756 Synergistic Compositions That Treat or Inhibit Pathological Conditions Associated With Inflammatory Response
07/12/2012US20120177698 Aggregates with increased deformability, comprising at least three amphipats, for improved transport through semi-permeable barriers and for the non-invasive drug application in vivo, especially through the skin
07/11/2012EP1682142B1 M3 muscarinic acetylcholine receptor antagonists
07/11/2012EP1678168B1 P70s6 kinase modulators and method of use
07/11/2012EP1615622B1 Once daily formulations of doxycyclines
07/11/2012EP1567188B1 Modified viral particles with immunogenic properties and reduced lipid content useful for treating and preventing infectious diseases
07/11/2012CN102552933A 蛋氨酸酶在抗蛋氨酸和抗高半胱氨酸的化学治疗中的应用 Methioninase used in chemotherapy anti-methionine and homocysteine ​​in the anti-
07/11/2012CN101497581B Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudomorphs thereof
07/10/2012US8216568 Combination therapy with IgA1 proteases
07/10/2012CA2542730C Anion-binding polymers and uses thereof
07/10/2012CA2499994C Abuse-resistant pharmaceutical compositions
07/10/2012CA2382336C Vaccines from infectious agents
07/10/2012CA2360003C Tricyclic inhibitors of poly(adp-ribose) polymerases
07/05/2012US20120171232 In vivo efficacy of ny-eso-1 plus adjuvant
07/05/2012US20120171124 Screening methods for cognitive enhancers
07/04/2012EP2471527A2 Facially amphiphillc polymers and oligomers and uses thereof
07/04/2012EP2471526A2 Facially amphiphillic polymers and oligomers and uses thereof
07/04/2012EP2471525A2 Facially amphiphllic polymers and oligomers and uses thereof
07/04/2012EP2471524A2 Facially amphiphllic polymers and oligomers and uses thereof
07/04/2012EP1689233B1 Bicyclic inhibitors of mek
07/04/2012CN1907967B Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudomorphs thereof
07/04/2012CN1901901B Taxoid-fatty acid conjugates and pharmaceutical compositions thereof
07/04/2012CN1893827B Silver dihydrogen citrate compositions comprising a second antimicrobial agent
07/04/2012CN1875028B Seneca valley virus based compositions and methods for treating disease
07/04/2012CN1791592B 免疫抑制剂化合物和组合物 Immunosuppressive compounds and compositions
07/04/2012CN102526079A 治疗脱髓鞘疾病的鞘氨醇-1-磷酸受体激动剂 Treatment of demyelinating diseases of the sphingosine-1-phosphate receptor agonist,
07/04/2012CN101898982B Npy y5 antagonists
07/04/2012CN101780092B Compounds and methods for delivery of prostacyclin analogs
07/04/2012CN101343302B Synthesis and manufacture of pentostatin and its precursors, analogs and derivatives
07/03/2012US8212079 Cocrystallization
07/03/2012US8211921 Heterocyclic inhibitors of MEK and methods of use
07/03/2012US8211451 Spill resistant formulations containing clays
07/03/2012US8211101 Systems and methods for treating hemorrhoids
07/03/2012CA2535953C Treating bone-related disorders with selective androgen receptor modulators
07/03/2012CA2525547C Compounds and uses thereof in modulating amyloid beta
06/2012
06/28/2012US20120165399 Snornai-small nucleolar rna degradation by rna interference in trypanosomatids
06/28/2012US20120165398 Pharmaceutical compositions and methods useful for modulating angiogenesis, inhibiting metastasis and tumor fibrosis, and assessing the malignancy of colon cancer tumors
06/28/2012US20120165348 Novel compounds
06/28/2012US20120164625 Methods for rapid identification of pathogens in humans and animals
06/27/2012EP2468299A2 Compositions for inducing immune responses
06/27/2012EP2468266A2 Pharmaceutical compositions for acute glucocorticoid therapy
06/27/2012EP2246360B1 Compositions for the treatment of gastrointestinal disorders
06/27/2012EP1589917B1 Methods of administering a dermatological agent to a subject
06/26/2012US8207294 Treatment of Aspergillus infections with alpha thymosin peptides
06/26/2012US8206740 Once daily formulations of tetracyclines
06/26/2012US8206704 Use of GCC ligands
06/26/2012CA2511970C Urea derivatives useful in the treatment of heart failure
06/26/2012CA2438582C Use of gal3 receptor antagonists for the treatment of depression and/or anxiety and compounds useful in such methods
06/21/2012US20120157514 Oligomeric compounds and compositions for use in modulation of small non-coding rnas
06/20/2012EP1771151B1 Composition, comprising hydrofluoric acid, for inhibiting dental erosion
06/20/2012CN1750758B Compounds for the treatment of metabolic disorders
06/20/2012CN102504014A Peptidomimetic protease inhibitors
06/20/2012CN102499984A Method of treatment and bioassay involving macrophage migration inhibitory factor (mif) as cardiac-derived myocardial depressant factor
06/19/2012US8202912 Pharmaceutical compositions providing enhanced drug concentrations
06/19/2012US8202834 Fat regulation
06/19/2012US8202517 Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof
06/19/2012CA2522784C Antiandrogens with marginal agonist activity and methods of use
06/14/2012US20120148555 Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof
06/13/2012EP2462923A2 Prevention of molecular weight reduction of the polymer, impurity formation and gelling in polymer compositions
06/13/2012EP2462896A1 Method for the preparation of controlled release formulations
06/13/2012EP1554311B1 Humanized antibodies that recognize beta amyloid peptide
06/13/2012EP0451216B2 Humanized immunoglobulins and their production and use
06/13/2012CN1849112B Therapeutic liposomes
06/13/2012CN101406469B Use of GAL3 receptor antagonists for the treatment of depression and/or anxiety and compounds useful in such methods
06/12/2012USRE43459 Intraoral discluder device and method for preventing migraine and tension headaches and temporomandibular disorders
06/12/2012US8198302 Anticancer agent having a quinone, quinone prodrug, catechol or catechol prodrug moiety; free of combretastatin A-1
06/12/2012US8198291 Intranasal opioid compositions
06/12/2012US8197824 Rapid, efficient purification of HSV-specific T-lymphocytes and HSV antigens identified via same
06/12/2012CA2534060C Hepatitis virus core proteins as vaccine platforms and methods of use thereof
06/07/2012US20120141560 Tumor and infectious disease therapeutic compositions
06/06/2012EP2460881A1 Proteoglycan degrading mutants for treatment of CNS
06/06/2012EP2460530A2 Human growth hormone crystals and methods for preparing them
06/06/2012EP1957155B1 Face mask
06/06/2012EP1661579B1 Method for treating systemic bacterial infection associated with changes of qualitative and/or quantitative composition of blood extracellular dna
06/06/2012EP1633718B1 COMPOSITIONS AND METHODS FOR INHIBITING TGF-s
06/06/2012EP1628530B1 Methods and compositions for the prevention and treatment of sepsis
06/06/2012EP1620108B1 Pyrazole-amine compounds useful as kinase inhibitors
06/06/2012EP1575526B1 Dna vaccines encoding heat shock proteins
06/06/2012CN1939304B Ascending-dose dosage form
06/06/2012CN1935839B Analogues of GLP-1
06/05/2012US8193252 Mesoprogestins (progesterone receptor modulators) for the treatment and prevention of benign hormone dependent gynecological disorders
06/05/2012US8193219 Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione
06/05/2012US8193185 Administering a tryptanthrin compound, e.g., 8-nitroindolo[2,1-b]quinazoline-6,12-dione, to potentiate the immune response to an antigen; immunostimulants; small molecule immune potentiators; immunotherapy for infectious diseases; anticarcinogenic agents; vaccine adjuvant compositions and kits
06/05/2012CA2548536C Pharmaceutical compounding systems and methods and information management system for same
06/05/2012CA2520000C Compositions and methods for treating cancer
06/05/2012CA2519278C Esterified fatty acid composition
05/2012
05/31/2012US20120135967 Lpa receptor agonists and antagonists and methods of use
05/30/2012EP1178808B1 Non-aqueous pharmaceutical composition for dermal use to treat psoriasis comprising a vitamin d, a corticosteroid and a solvent component
05/30/2012CN1703238B Recombinant intracellular pathogen immunogenic compositions and methods for use
05/30/2012CN101579344B Low hygroscopic aripiprazole drug substance and processes for the preparation thereof
05/29/2012US8188239 Multivalent carriers of bi-specific antibodies
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 ... 295